Dr. Donald C. Lanza, MD

Dr. Lanza practices at Sinus & Nasal Institute of Florida PA in Saint Petersburg, Florida.

Dr. Lanza's NPI, 1700843885, was assigned on May 1, 2006. Dr. Lanza graduated from SUNY Downstate Health Sciences University in 1985. Dr. Lanza holds Florida license ME88591.

Dr. Lanza's primary practice is Sinus & Nasal Institute of Florida PA, at 550 94th N Ave, Saint Petersburg, FL 33702 in Pinellas County. The practice phone is (727) 573-0074.

Dr. Lanza's primary practice is Sinus & Nasal Institute of Florida PA in Saint Petersburg, Florida. Dr. Lanza is also affiliated with BayCare St. Anthony's Hospital. The medical group on file is Sinus & Nasal Institute of Florida. Dmand AI also links Dr. Lanza to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lanza practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Lanza's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Lanza is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Lanza's licenses on file in 5 states: Florida, New York, Ohio, Pennsylvania and Maryland.

Dmand AI lists chronic nasal allergies, chronic sinusitis and endoscopic sinus surgery among the conditions Dr. Lanza treats.

CMS data shows 927 Medicare services from Dr. Lanza across 7 procedure codes in 2024, for 262 Medicare patients. Medicare paid $118,364 for them. Every service was in an office.

CMS counts 262 Medicare patients who saw Dr. Lanza in 2024. The largest group is 65 to 74, with 122 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lanza's median patient age at 67, with 47% women.

In 2024, Dr. Lanza wrote 1,471 Medicare Part D claims for 305 patients. 87% of them were for generic drugs. CMS names the drug for 1,323 of them, across 21 drugs with 11 or more claims each, at $121,018 in total drug cost. In 2023, CMS named 1,489 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Lanza for performance year 2024, reported as part of a group. Dr. Lanza accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 93 papers to Dr. Lanza, published from 2005 to 2020. 2011 was the busiest year, with 4. The most frequent topics are Endoscopy, Sinusitis and Tomography, X-Ray Computed. Dr. Lanza has published most often in Am J Rhinol. Dr. Lanza's most frequent co-authors are Martin J. Citardi, MD, Jeb Mahan Justice, MD and William E. Bolger, MD.

CMS Open Payments shows 9 general payments to Dr. Lanza from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Allergan Inc. paid the most, $168.

Dmand AI lists 11 awards for Dr. Lanza, most recently America's Top Doctors for Cancer in 2023.

Dr. Lanza graduated from SUNY Downstate Health Sciences University in 1985. Dr. Lanza is a member of NHS and ACS.

Dr. Lanza is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.